Abstract
This document, produced with the assistance of GPT-5.2 Thinking and Gemini 3 Reasoning, is released under the Apache License 2.0. It is a voluntary defensive publication (prior art) and therefore enters the prior art upon release under the applicable patent statutes: EPC Art. 54(2) (European Patent Convention), French IPC Art. L 611-11 (French Intellectual Property Code), 35 U.S.C. §102(a) (United States Patent Act), Chinese Patent Law Art. 22(5) (両匡丢氡儡吡嘡丣刡氢), and Japanese Patent Act Art. 29(1) (闘旧避). This document consolidates an enabling extraction of sixty (60) potentially patentable/defensive ideas for the BSCC-V1 concept: coherent emissions (528 Hz and harmonics), silica micro-resonators, closed-loop control driven by biophotons/HRV/EEG, active interference cancellation, 3D field mapping, ultraweak-photon metrology and AI-assisted low-light imaging, adaptive/circadian protocols, bio-EM safety, interoperability (FHIR), supply-chain traceability, microfabrication processes, and wearable/implant/agri/veterinary variants.
Original Zenodo url: https://zenodo.org/records/18121282
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
Pillet, Xavier, "Strategic Report: BSCC-V1 Device for Preserving Epigenetic Integrity", Technical Disclosure Commons, (January 02, 2026)
https://www.tdcommons.org/dpubs_series/9110